Cite

HARVARD Citation

    Schaenman, J. et al. (2021). Early cytomegalovirus DNAemia and antiviral dose adjustment in high vs intermediate risk kidney transplant recipients. Transplant infectious disease. 23 (1), p. n/a. [Online]. 
  
Back to record